课题基金 / 基金详情

Investigation of p21 in the molecular mechanisms of lung injury and pulmonary fibrosis

Investigation of p21 in the molecular mechanisms of lung injury and pulmonary fibrosis
p21在肺损伤和肺纤维化分子机制中的研究
批准号:
15590813
负责人:
FUJITA Masaki
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

FUJITA Masaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1.Transforming Growth Factor-β1 as an Enhancer of Fas-mediated Apoptosis of Lung Epithelial CellsTransforming growth factor-β1(TGF-β1) has important roles in lung fibrosis and the potential to induce apoptosis in several types of cells. We previously demonstrated that apoptosis of lung epithelial cells induced by Fas ligation may be involved in the development of pulmonary fibrosis. Here we show that TGF-β1 induces apoptosis of primary cultured bronchiolar epithelial cells via caspase-3 activation and downregulation of cyclin-dependent kinase inhibitor p21. Concentrations of TGF-β1 that were not sufficient to induce apoptosis alone could enhance agonistic anti-Fas antibody or recombinant Fas ligand-mediated apoptosis of cultured bronchiolar epithelial cells. Soluble Fas ligand in the bronchoalveolar lavage fluid(BALF) from patients with idiopathic pulmonary fibrosis(IPF) also induced apoptosis of cultured bronchiolar epithelial cells that was significantly attenuated by anti-TGF-β anti … More body. Otherwise, BALF from patients with hypersensitivity pneumonitis(HP) could not induce apoptosis on bronchiolar epithelial cells despite its comparable amounts of soluble Fas ligand. The concentrations of TGF-β1 in BALF from patients with IPF were significantly higher compared with those in BALF from patients with HP or controls. Furthermore, co-incubation with the low concentration of TGF-β1 and HP BALF created pro-apoptotic effects comparable to the IPF BALF. In vivo, the administration of TGF-β1 could enhance Fas-mediated epithelial cell apoptosis and lung injury via caspase-3 activation in mice. Our results demonstrate a novel role of TGF-β1 in the pathophysiology of pulmonary fibrosis as an enhancer of Fas-mediated apoptosis of lung epithelial cells.2.In vivo gene transfer of mutant MCP-1 attenuates pulmonary fibrosisAlveolar epithelial cells are known to be present at the primary site of lung damage in pulmonary fibrosis. Apoptosis has been implicated as being involved in epithelial cell damage and pulmonary fibrosis. Since the cyclin-dependent kinase inhibitor p21 induces G1 arrest and DNA repair, and since it also prevents apoptosis in some cells, we hypothesized that p21 gene transfer may attenuate bleomycin-induced pulmonary fibrosis in mice, the pathogenesis of which likely involves epithelial cell apoptosis. Human p21 protein was expressed in mouse alveolar epithelial cells at 1 to 7 days in vitro and was detected predominantly in lung epithelial cells at 1 to 7 days in vivo after adenoviral transfer of the human p21 gene. Inflammatory cell infiltration and fibrosis had already begun at 7 days in this model. Adenoviral transfer of the human p21 gene at 7days after intratracheal instillation of bleomycin led to a decrease in the number of apoptotic cells, lung inflammation and fibrosis at 14 days. Therefore, the forced expression of p21 exerted both anti-apoptotic and anti-fibrotic effects, which would facilitate the ultimate goal of treatment for pulmonary fibrosis. Less
期刊论文(43)
专著(0)
科研奖励(0)
会议论文
Serum CC-10 in Inflammatory Lung Diseases
炎症性肺病中的血清 CC-10
DOI: --
发表时间: 2004
期刊: Respiration 71
影响因子: --
作者: [Ye Q, et al.]
通讯作者: et al.
DOI: 10.1136/jcp.2003.015495
发表时间: 2004-12-01
期刊: JOURNAL OF CLINICAL PATHOLOGY
影响因子: 3.4
作者: [Miyazaki, H, Kuwano, K, Nakanishi, Y]
通讯作者: Nakanishi, Y
DOI: 10.2174/1573406053402497
发表时间: 2005
期刊: Medicinal chemistry (Shariqah (United Arab Emirates))
影响因子: --
作者: [K. Kuwano;M. Yoshimi;T. Maeyama;N. Hamada;M. Yamada;Y. Nakanishi]
通讯作者: K. Kuwano;M. Yoshimi;T. Maeyama;N. Hamada;M. Yamada;Y. Nakanishi
Induction of CDK inhibitor p21 gene as a new therapeutic strategy against pulmonary fibrosis pulmonary fibrosis
诱导CDK抑制剂p21基因作为抗肺纤维化的新治疗策略 肺纤维化
DOI: --
发表时间: 2004
期刊: Am J Physiol Lung Cell Mol Physiol 286
影响因子: --
作者: [Kuwano K, Yoshimi M, Maeyama T, Hamada N, Yamada M, Nakanishi Y, Inoshima I et al.]
通讯作者: Inoshima I et al.
16
    Establishment of neutron spin prism method and study of electron multi-dynamics of superconductors
    • 批准号:
      16H02125
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $26.37万
    • 财政年份:
      2016
    • 负责人:
      FUJITA Masaki
    • 依托单位:
    Cloning and Expression of Siderophore Biosynthetic Gene Clusters from Marine Metagenome
    • 批准号:
      23790134
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.83万
    • 财政年份:
      2011
    • 负责人:
      FUJITA Masaki
    • 依托单位:
    Study of multi-dynamics of electronic degrees of freedom in high-Tc cuprate superconductor
    • 批准号:
      23340093
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.56万
    • 财政年份:
      2011
    • 负责人:
      FUJITA Masaki
    • 依托单位:
    Synthesis of high-Tc superconducting crystal and study of spin and lattice dynamics by neutron scattering techniques
    • 批准号:
      20540342
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2008
    • 负责人:
      FUJITA Masaki
    • 依托单位:
    海外基金